An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

(IN BRIEF) An international team of researchers has made a significant breakthrough in Alzheimer’s drug development with the introduction of RI-AG03, a novel peptide inhibitor that targets and ...

“This research is taking promising steps toward a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...